Abstract

Melatonin, a hormone of the pineal gland, has been labelled with the positron-emitting radionuclide, carbon-11 ( t 1 2 = 20.4 min ), for study in vivo by positron emission tomography. Thus a novel labelling agent, [ 11C]acetyl chloride, was prepared by the carbonation of methylmagnesium bromide with cyclotron-produced [ 11C]carbon dioxide followed by treatment with phthaloyl dichloride. Acylation of 5-methoxytryptamine then affords [ 11C]melatonin, which is purified by HPLC and formulated for intravenous injection. The preparation requires 35 min from the end of radionuclide production. It provides [ 11C]melatonin in 13% radiochemical yield (decay-corrected from 11CO 2) and in high specific activity. Radiochemical and chemical purity were demonstrated by HPLC and TLC. The validity of the radiosynthesis was also confirmed by a parallel synthesis of [ 13C]melatonin and examination of the product by 13C-NMR spectroscopy and mass spectrometry.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.